1. WHO : World Malaria Report 2010.

2. Harijanto PN. Malaria. Dalam: Sudoyo AW, Setiyohadi B, Alwi I, Simadibrata M,

Setiati S, Syam AF, editors. Buku Ajar Ilmu Penyakit Dalam. Edisi VI. Jakarta: Interna
publishing; 2015. hl 595-611.
3. Crawley J, Chu C, Mtove G, Nosten F. Malaria in children. Lancet. 2010;375:1468–81.
4. Bulletin jendela data dan informasi kesehatan. Epidemiologi malaria di Indonesia.
Kementerian kesehatan RI. Jakarta. 2011.hal 1-32.
5. White NJ.: Malaria. In : Cook GC (Ed). Manson's Tropical Disease, 20th ed.,London:
W.B. Saunders; 1996 : 1087 - 64

6. Miller L H . The pathogenic basis of Malaria. Nature 2002, 415 : 673-9

7. Langi J, Harijanto, Richie T L :L Patogenesa Malaria Berat. Dalam Harijanto PN (ed).

Malaria. Epidemiologi, Patogenesa, Manifestasi klinik dan Penanganan, EGC, 2000
:118 - 27.

8. Tambayong, EH : Patobiologi Malaria. EGC 2000 : 54 - 117.

9. Noviyanti Rintis: Patogenesis Molekuler Plasmodium falciparum Malaris: Struktur

Genom dan implikasinya. Dalam. Harijanto PN, Nugroho A, Gunawan CA . Malaria.
Dari Molekuler ke Klinis. EGC 2010 :

10. White NJ: Plasmodium Knowlesi : The Fifth Human Malaria Parasite, (editorial)
Clinical Infectious Diseases 2008; 46:172-3.

11. Cox-Singh J, Davis TM, Lee K-S, et al. Plasmodium knowlesi malaria in humans is
widely distributed and potentially life threatening. Clin. Infect Dis 2008; 46:165-71

12. Fairhurst RM, WellemsTE: Plasmodium spesies (Malaria). In. G.L. Mandell, J.E.
Bennett, R. Dolin (eds). Mandell, Douglas and Bennett's Principles and Practice of
Infectious Diseases..7th edition. U.S.A: Churchill Livingstone; 2010.p. 3437 - 62.

13. Harinasuta T & Bunnag D : The clinical features of malaria. In: Wernsdorfer WH &
McGregor SI (eds). Malaria. Principles and Practice of Malariology, Churchill
Livingstone, London, 1988, vol.1:709-34.

14. Price RN, Tjitra E, Guerra CA et all: Vivax Malaria . Negleted and not benign. Am J
Trop Med Hyg. 2007; 77(6 Suppl): 79-87.

15. Tjitra E, Anstey NM, Sugiarto P et all : Multidrug-resistant Plasmodium Vivax

Associated with severe and fatal Malaria : A Prospective study in Papua, Indonesia.
Plos Medicine 2008; 5 (6) : 890-9

16. Archna Sharma & Uma Khanduri :How benign is benign tertian malaria. J. Vector
Borne Dis 2009, 49 :141-4 Daneshvar C, Davis TME, Cox-Singh et all. : Clinical and
 Laboratory Features of Human Malaria Knowlesi Infection. Clinical Infectious
Diseases 2009; 49 : 852 -60.

17. Sutanto I, Endawat D, Liem Hui Ling et all : Evaluation of chloroquine therapy for
vivax and falciparum malaria in southern Sumatra western Indonesia. Malaria journal
2010; 9: 52 - 9

18. William T, Menon J, Rajahram G et all : Severe Plasmodium Knowlesi Malaria in a

Tertiary Care Hospital, Sabah Malaysia. Emerging Infect Dis 2011,17 (7): 1248 - 55.

19. Sabbatani S, Fiorino S, Manfredi R : The Emerging of the fifth malaria parasite (
Plasmodium Knowlesi). A Public health concern ? Braz J Infec Dis 2010; 14 (3): 299 -
309

20. TangPukdee N, Duangdee C, Wilairatana P et all : Malaria Diagnosis : A Brief Review.

Karean J Parasitologi 2009, 47 (2): 93 - 102.

21. WHO : Severe Falciparum Malaria. Transactions of the Royal Society of Tropical
Medicine and Hygiene, 2000

22. WHO: Antimalarial Drug Combination Therapy. Report of a WHO Technical

Consultation, April 2001

23. Woodrow CJ, Haynes RK and Krishna S : Review. Artemisiniiis. Postgraduate Medical
Journal 2005; 81:71-8

24. White NJ: Qinghaosu (Artemisinin): The Price of Success. Science, 2008 ; 320 : 330 -
334

25. P2M DepKes RI : Tatalaksana Pengobatan Malaria, 2010, Ditjen P2M, Direktorat
Malaria, DepKes RI